Homocysteine and lipid levels in young patients with coronary artery disease

A Puri1, O K Gupta, R N Dwivedi

  • 1KPS Post Graduate Institute of Medicine; +Professor and Head, LPS Institute of Cardiology, GSVM Medical College, Kanpur.

Insights

Elevated homocysteine is a significant independent risk factor for premature coronary artery disease (CAD) in young Indian patients. This novel risk factor should be evaluated, especially when traditional risk factors are absent.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Public Health

Background:

  • Coronary artery disease (CAD) affects Indians prematurely.
  • Homocysteine is a recognized risk factor for CAD.
  • The role of homocysteine in young Indian CAD patients requires further investigation.

Purpose of the Study:

  • To determine the independent association of homocysteine with traditional risk factors in young Indian CAD patients.
  • To highlight the importance of homocysteine as a novel risk factor in this population.

Main Methods:

  • Study included 51 young CAD patients (< 45 years) and 15 healthy controls.
  • Patients were divided into hyperlipidemic and normolipidemic subgroups.
  • Plasma homocysteine levels were measured using high-pressure liquid chromatography.

Main Results:

  • Mean homocysteine levels were significantly higher in CAD patients (27.8 nmol/ml) compared to controls (13.22 nmol/ml).
  • Over 72% of young CAD patients had homocysteine levels above the cut-off (18 nmol/ml).
  • Homocysteine levels were elevated regardless of the patient's lipid profile.

Conclusions:

  • Plasma homocysteine is a significant independent risk factor for premature CAD in young Indians.
  • Homocysteine evaluation is recommended for young CAD patients, particularly those without traditional risk factors.
  • The findings underscore the need to recognize homocysteine's role in cardiovascular risk stratification.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...